Sign up to save your podcasts
Or
Share Episode 05 - Christina Trojel-Hansen, EIR ARCH Venture Partners
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 05 - Christina Trojel-Hansen, EIR ARCH Venture Partners
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
We’re excited to host Dr. Christina Trojel-Hansen. Christina is a leading figure in biotech, having co-founded several innovative companies, including Tune Therapeutics, which specializes in gene regulation technology, Oscine Therapeutics, which is making significant advancements in CNS cell therapy, and Pretzel Therapeutics, focused on mitochondrial diseases.
As an Entrepreneur in Residence at ARCH Venture Partners, Christina has played a pivotal role in transforming early-stage ideas into viable medical breakthroughs.
Christina’s strategic insight has also been instrumental in
securing major Series A investments for biotech innovators like Adcendo and Stipe Therapeutics.
Her leadership and vision have earned her a place among the Top 10 Inspirational Women in Nordic Life Science and the Endpoints 20 under 40, highlighting her as a future leader in biotech.
Join us as we delve into her story of entrepreneurship,
innovation, and leadership in the biotech landscape.
Enjoy and stay tuned
View all episodes
By Max Brennan - Biotech HeadHunterWelcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
We’re excited to host Dr. Christina Trojel-Hansen. Christina is a leading figure in biotech, having co-founded several innovative companies, including Tune Therapeutics, which specializes in gene regulation technology, Oscine Therapeutics, which is making significant advancements in CNS cell therapy, and Pretzel Therapeutics, focused on mitochondrial diseases.
As an Entrepreneur in Residence at ARCH Venture Partners, Christina has played a pivotal role in transforming early-stage ideas into viable medical breakthroughs.
Christina’s strategic insight has also been instrumental in
securing major Series A investments for biotech innovators like Adcendo and Stipe Therapeutics.
Her leadership and vision have earned her a place among the Top 10 Inspirational Women in Nordic Life Science and the Endpoints 20 under 40, highlighting her as a future leader in biotech.
Join us as we delve into her story of entrepreneurship,
innovation, and leadership in the biotech landscape.
Enjoy and stay tuned